PXSAX
Price
$19.89
Change
+$0.15 (+0.76%)
Updated
Dec 11 closing price
Net Assets
754.75M
VSCIX
Price
$127.56
Change
+$1.43 (+1.13%)
Updated
Dec 11 closing price
Net Assets
163.34B
Interact to see
Advertisement

PXSAX vs VSCIX

Header iconPXSAX vs VSCIX Comparison
Open Charts PXSAX vs VSCIXBanner chart's image
Impax Small Cap A
Price$19.89
Change+$0.15 (+0.76%)
VolumeN/A
Net Assets754.75M
Vanguard Small Cap Index I
Price$127.56
Change+$1.43 (+1.13%)
VolumeN/A
Net Assets163.34B
PXSAX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
PXSAX vs. VSCIX commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PXSAX is a StrongBuy and VSCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 163B vs. PXSAX (755M). VSCIX pays higher dividends than PXSAX: VSCIX (1.33) vs PXSAX (0.00). PXSAX was incepted earlier than VSCIX: PXSAX (13 years) vs VSCIX (28 years). PXSAX (1.15) is less costly to investors than VSCIX (0.04). PXSAX is a more actively managed with annual turnover of: 48.00 vs. VSCIX (13.00). PXSAX has a lower initial minimum investment than VSCIX: PXSAX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 4.24 vs. PXSAX (2.87). VSCIX return over 5 years is better than : 42.77 vs. PXSAX (26.31).
PXSAXVSCIXPXSAX / VSCIX
Total Expense Ratio1.150.042,875%
Annual Report Gross Expense Ratio1.150.042,875%
Fund Existence13 years28 years-
Gain YTD13.97211.042127%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets755M163B0%
Annual Yield % from dividends0.001.33-
Returns for 1 year2.874.2468%
Returns for 3 years36.7041.6588%
Returns for 5 years26.3142.7762%
Returns for 10 years51.95153.4734%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFR129.953.31
+2.61%
Cullen/Frost Bankers
UFPT213.793.72
+1.77%
UFP Technologies
FGNXP20.490.19
+0.92%
Fundamental Global Inc
NMRA2.090.01
+0.72%
Neumora Therapeutics
MDAI1.70-0.02
-1.16%
Spectral AI